Hertzel Gerstein on dulaglutide, erectile dysfunction, and T2D

The Lancet Diabetes & Endocrinology in conversation with

English - July 09, 2021 12:00 - 24 minutes - 16.5 MB
Life Sciences Science Education diabetes insulin Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: In conversation with... Rishi Caleyachetty

Next Episode: Victoria Salem on improving female inclusion in conferences

Hertzel Gerstein talks with The Lancet Diabetes & Endocrinology about how dulaglutide might reduce the incidence of moderate or severe erectile dysfunction in men with type 2 diabetes.

Read the full article:
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00115-7/fulltext

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv